7.45
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Puma Biotechnology reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Six new Puma hires get stock awards covering 59,750 shares - Stock Titan
MSN Money - MSN
Puma Biotechnology (PBYI) to Release Quarterly Earnings on Thursday - MarketBeat
PBYI Stock Price, Quote & Chart | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill
PBYI SEC FilingsPuma Biotechnology Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Puma Biotechnology (NASDAQ:PBYI) Stock Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat
Puma Biotechnology | 10-Q: Q2 2025 Earnings Report - Moomoo
CEO warrant extension and pay vote at Puma Biotechnology (NASDAQ: PBYI) meeting - Stock Titan
[ARS] PUMA BIOTECHNOLOGY, INC. SEC Filing - Stock Titan
Puma Biotechnology (PBYI) Stock Price Alert (Technical Strength) 2026-04-27Investment Picks - Newser
Puma Biotechnology stock declines more than 9% in a month: Here's why - MSN
Press Release: Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results - 富途牛牛
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results - BioSpace
Puma Biotechnology (NASDAQ:PBYI) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Ritholtz Wealth Management Boosts Stake in Puma Biotechnology - National Today
Puma Biotechnology, Inc. $PBYI Shares Acquired by Ritholtz Wealth Management - MarketBeat
Is Puma Biotechnology (PBYI) Stock Attractive Now | Price at $7.72, Down 0.96%Sentiment Analysis - Cổng thông tin điện tử tỉnh Lào Cai
What Do Analysts Think About Puma Biotechnology (PBYI)? - MSN
Puma Biotechnology (NASDAQ:PBYI) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Puma Biotechnology Stock Surges Past 200-Day Average - National Today
Puma Biotechnology (NASDAQ: PBYI) seeks votes to extend CEO warrant, elect directors - Stock Titan
Can Puma Biotechnology Inc sustain its profitabilityWeekly Stock Analysis & Real-Time Market Trend Scan - baoquankhu1.vn
PBYI PE Ratio & Valuation, Is PBYI Overvalued - Intellectia AI
Investor Mood: Is Puma Biotechnology Inc undervalued by DCF analysisWeekly Stock Report & AI Forecasted Stock Moves - baoquankhu1.vn
PBYI Stock Analysis: Puma Biotechnology Inc holds 6.9 level after 2.07 pct gain - Cổng thông tin điện tử tỉnh Tây Ninh
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last? - qz.com
Pharma News: Is Puma Biotechnology Inc a momentum stockAnalyst Downgrade & Capital Efficiency Focused Ideas - baoquankhu1.vn
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Recap Report: What is Puma Biotechnology Incs 5 year growth outlook2026 Technicals & Low Risk Growth Stock Ideas - baoquankhu1.vn
Puma Biotechnology Q4 2025 slides: NERLYNX revenue rises 15% sequentially - Investing.com
Earnings call transcript: Puma Biotechnology Inc. reports strong Q4 2025 results - in.investing.com
Vanguard disaggregates holdings; Puma Biotechnology (PBYI) shows 0 shares reported - stocktitan.net
Forecast Cut: Is Puma Biotechnology Inc a momentum stockPortfolio Update Report & Risk Managed Trade Strategies - baoquankhu1.vn
Rate Hike: Can Puma Biotechnology Inc be the next market leaderPortfolio Update Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Wall Street Zen Upgrades Puma Biotechnology (NASDAQ:PBYI) to Strong-Buy - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):